Kyle Kuhn has a robust background in business development within the biopharmaceutical sector, currently serving as Senior Director of Externalization at Takeda. Prior roles include Senior Vice President of Business Development at Emendo Biotherapeutics and Senior Director of Business Development at Casebia Therapeutics and Acorda Therapeutics. Kyle also held the position of Director of Business Development at Acorda Therapeutics and served as a Senior Consultant in Business Development at Campbell Alliance. This extensive experience reflects a deep expertise in strategic partnerships and external collaboration in the healthcare industry.